AzTrials
AzTrials

AnaesthesiaKTHYPENCT02662322

Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE)

A study testing Hypnotic communication, negative connotation communication and neutral connotation communication in people with Anaesthesia, run by Rennes University Hospital at 3 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare three communications during peripheral intravenous catheterization and measure pain patient: one hypnotic, confusion (HYPNOSIS), an other with negative connotation (NOCEBO) and at least with neutral connotation (NEUTRAL). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anaesthesia
What is being tested?
Hypnotic communication, negative connotation communication and neutral connotation communication
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
294 participants
Where
3 sitesin 2 countries
Study dates
10 Mar 2016to 6 Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • at least 18 years
  • peripheral intravenous catheterization of 20 G on the dorsal face of the hand before a planned surgery
  • written and informed patient consent
  • Non inclusion Criteria:
  • patient unable to communicate in french
  • difficult vein access characteristics
Show all 9Show fewer
  • premedication
  • pregnant, breast-feeding woman
  • patient subject of legal protection

Who cannot join

  • failed of the first attempt of peripheral intravenous catheterization

Trial locations and contacts

3 sites in 2 countries.

3 sites in 2 countries

France2 sites
  • CHU

    Rennes, 35033

  • Centre Hospitalier Privé Saint Grégoire

    Saint-Grégoire, 35768

Other trials in France

Belgium1 site
  • Cliniques Universitaires Saint-Luc

    Brussels, 10 1200

Other trials in Belgium

About this study

Official title: Effect of Language and Confusion on Pain During Peripheral Intravenous

The purpose of this study is to compare three communications during peripheral intravenous catheterization and measure pain patient: one hypnotic, confusion (HYPNOSIS), an other with negative connotation (NOCEBO) and at least with neutral connotation (NEUTRAL).

Read the detailed description

Clinicians used to warn patients of pain or discomfort before potentially painful procedures like peripherical intravenous catheterization (PIVC). However, suggestions for negative perceptual experiences causes more pain and anxiety. During This does not improve at all the real-life experience of the act. On the contrary, the use of gentler words improves pain perception and subjective patient experience. Furthermore, hypnosis has been demonstrated as efficient and the pain perception seems to be modulate by hypnotic suggestions.

Conditions
Anaesthesia
Being tested
Hypnotic communication, negative connotation communication, neutral connotation communication, peripheral intravenous catheterization
Keywords
Communication, Confusion, Intravenous Catheterization, Comfort
Medical subject headings
Communication, Confusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnotic communicationOther

    hypnotic communication during peripheral intravenous catheterization

  • negative connotation communicationOther

    negative connotation communication during peripheral intravenous catheterization

  • neutral connotation communicationOther

    neutral connotation communication during peripheral intravenous catheterization

  • peripheral intravenous catheterizationOther

    peripheral intravenous catheterization

Study groups in NCT02662322
Study groupRoleWhat they receive
HYPNOSISExperimentalhypnotic communication, confusion procedure during peripheral intravenous catheterization
Receives: Other: Hypnotic communication; Other: peripheral intravenous catheterization
NOCEBOActive comparatornegative connotation communication during peripheral intravenous catheterization
Receives: Other: negative connotation communication; Other: peripheral intravenous catheterization
NEUTRALPlacebo comparatorneutral connotation communication during peripheral intravenous catheterization
Receives: Other: neutral connotation communication; Other: peripheral intravenous catheterization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. numerical rating scale for pain from 0 to 10

    self-evaluation of pain catheterization

    Measured: data collected within 3 min after the end of peripheral intravenous catheterization procedure

Secondary outcomes (4)
  1. evolution of numerical rating scale for comfort from 0 to 10

    self-evaluation of comfort catheterization

    Measured: data collected just before and within 3 min after peripheral intravenous catheterization procedure

  2. evolution of numerical rating scale for anxiety from 0 to 10

    self-evaluation of anxiety catheterization

    Measured: data collected just before and within 3 min after peripheral intravenous catheterization procedure

  3. presence of spontaneous patient arm withdrawal

    Measured: data collected within 3 min after the end of peripheral intravenous catheterization procedure

  4. presence of unprompted vocalization by word(s) or sound(s)

    Measured: data collected within 3 min after the end of peripheral intravenous catheterization procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2016 (estimated)
  2. Study start10 Mar 2016
  3. Primary completion6 Mar 2017
  4. Study completion6 Sep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
294 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02662322
Sponsor's protocol ID
35RC15_9868
Acronym
KTHYPE
Status last verified
May 2018
First submitted
12 Jan 2016
Last updated
7 May 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Fusco N, Bernard F, Roelants F, Watremez C, Musellec H, Laviolle B, Beloeil H; Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE) group. Hypnosis and communication reduce pain and anxiety in peripheral intravenous cannulation: Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE), a multicentre randomised trial. Br J Anaesth. 2020 Mar;124(3):292-298. doi: 10.1016/j.bja.2019.11.020. Epub 2019 Dec 18.

    PubMed 31862159

Questions about this trial

What is this clinical trial studying?

A study testing Hypnotic communication, negative connotation communication and neutral connotation communication in people with Anaesthesia, run by Rennes University Hospital at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France, Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

numerical rating scale for pain from 0 to 10 (time frame: data collected within 3 min after the end of peripheral intravenous catheterization procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02662322, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in